Cognition Therapeutics

Developer of small molecule drugs for neurodegenerative diseases

placePittsburgh, Pennsylvania, United States calendar_todayFounded 2007 groups25 employees language cogrx.com

Registered entities

Social engagement

Social engagement: 6.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

30 investors on record; lead investors include Golden Seeds.

Investor typeCountShare
Venture capital1447%
Private equity27%
Angel & family office723%
Accelerator & incubator13%
Other / undisclosed620%

Recent activity

12 Jun 2026
Event
Neuro Perspectives Expert Summit virtual fireside chat
4 Jun 2026
Event
2026 @Jefferies Global Healthcare Conference
Coming soon